Cumulative Dose Response Study Comparing HFA-134a Albuterol Sulfate and Conventional CFC Albuterol in Patients with Asthma

This publication has 19 references indexed in Scilit:

• The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
  Journal of the American Academy of Dermatology, 1996
• Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol
  British Journal of Clinical Pharmacology, 1996
• Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma
  Journal of Allergy and Clinical Immunology, 1995
• Dose response to inhaled salbutamol in chronic obstructive airways disease
  Published by Oxford University Press (OUP) ,1991
• Issues Surrounding MDI Formulation Development with Non-CFC Propellants
  Journal of Aerosol Medicine, 1991
• Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma
  The Lancet, 1990
• The CFC-Ozone Issue: Progress on the Development of Alternatives to CFCs
  Science, 1990
• Model calculations of the relative effects of CFCs and their replacements on global warming
  Nature, 1990
• The biochemical effects of high-dose inhaled salbutamol in patients with asthma
  European Journal of Clinical Pharmacology, 1989
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
  Journal of Pharmacokinetics and Biopharmaceutics, 1987